UA93901C2 - Vaccine against mycoplasma prrs - Google Patents
Vaccine against mycoplasma prrsInfo
- Publication number
- UA93901C2 UA93901C2 UAA200812024A UAA200812024A UA93901C2 UA 93901 C2 UA93901 C2 UA 93901C2 UA A200812024 A UAA200812024 A UA A200812024A UA A200812024 A UAA200812024 A UA A200812024A UA 93901 C2 UA93901 C2 UA 93901C2
- Authority
- UA
- Ukraine
- Prior art keywords
- prrs
- vaccine against
- vaccine
- against mycoplasma
- immunogenic
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 4
- 241000204031 Mycoplasma Species 0.000 title 1
- 230000002163 immunogen Effects 0.000 abstract 3
- 241000204045 Mycoplasma hyopneumoniae Species 0.000 abstract 1
- 208000005342 Porcine Reproductive and Respiratory Syndrome Diseases 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 230000002238 attenuated effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
The present invention relates to the use of an immunogenic dose of immunogenic material of Mycoplasma hyopneumoniae and an immunogenic dose of live attenuated PRRS virus for the manufacture of a vaccine, and to a vaccine kit comprising such a vaccine.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06112444 | 2006-04-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA93901C2 true UA93901C2 (en) | 2011-03-25 |
Family
ID=37114256
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200812024A UA93901C2 (en) | 2006-04-10 | 2007-04-06 | Vaccine against mycoplasma prrs |
Country Status (7)
| Country | Link |
|---|---|
| CN (1) | CN101420975B (en) |
| AT (1) | ATE535253T1 (en) |
| BR (1) | BRPI0710550A2 (en) |
| DK (1) | DK2007419T3 (en) |
| ES (1) | ES2377576T3 (en) |
| RU (1) | RU2408386C2 (en) |
| UA (1) | UA93901C2 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2571980A4 (en) | 2010-05-19 | 2014-02-26 | Bioproperties Pty Ltd | Methods relating to an attenuated mycoplasma |
| UA114504C2 (en) * | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | PCV, MYCOPLASMA HYOPNEUMONIA AND PRRS COMBINED VACCINE |
| UA114503C2 (en) * | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | PCV AND MYCOPLASMA HYOPNEUMONIA COMBINED VACCINE |
| CN104248759B (en) * | 2013-11-19 | 2017-05-10 | 普莱柯生物工程股份有限公司 | Vaccine composition, preparation method and application thereof |
| JP7513614B2 (en) | 2018-12-20 | 2024-07-09 | インターベット インターナショナル ベー. フェー. | Prime-boost vaccination regimen |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7018638B2 (en) * | 2000-12-19 | 2006-03-28 | Wyeth | Mycoplasma hyopneumoniae bacterin vaccine |
| WO2005112995A1 (en) * | 2004-04-26 | 2005-12-01 | Choongang Vaccine Laboratory Co., Ltd. | Inactivated mixed vaccine for porcine respiratory disease and the method of manufacturing thereof |
-
2007
- 2007-04-06 AT AT07727888T patent/ATE535253T1/en active
- 2007-04-06 RU RU2008144180/15A patent/RU2408386C2/en not_active IP Right Cessation
- 2007-04-06 BR BRPI0710550-9A patent/BRPI0710550A2/en not_active Application Discontinuation
- 2007-04-06 CN CN2007800129701A patent/CN101420975B/en not_active Expired - Fee Related
- 2007-04-06 ES ES07727888T patent/ES2377576T3/en active Active
- 2007-04-06 UA UAA200812024A patent/UA93901C2/en unknown
- 2007-04-06 DK DK07727888.5T patent/DK2007419T3/en active
Also Published As
| Publication number | Publication date |
|---|---|
| ATE535253T1 (en) | 2011-12-15 |
| CN101420975A (en) | 2009-04-29 |
| CN101420975B (en) | 2012-06-27 |
| RU2408386C2 (en) | 2011-01-10 |
| ES2377576T3 (en) | 2012-03-29 |
| RU2008144180A (en) | 2010-05-20 |
| BRPI0710550A2 (en) | 2011-08-16 |
| DK2007419T3 (en) | 2012-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1120347T1 (en) | VIRTUAL SHEPHERD VIRUS vaccine | |
| UA100507C2 (en) | Prevention and treatment of sub-clinical pcvd | |
| MX2010008799A (en) | Process for stabilizing an adjuvant containing vaccine composition. | |
| EA201100268A1 (en) | VACCINE | |
| CL2013002379A1 (en) | Porcine reproductive and respiratory syndrome virus (prrsv); procedure for the preparation of live attenuated prrsv; vaccine that comprises it and its preparation procedure; and procedure to immunize pigs against porcine reproductive and respiratory syndrome. | |
| PH12015501637A1 (en) | Inactivated dengue virus vaccine with aluminium-free adjuvant | |
| MX355683B (en) | Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use. | |
| BRPI0606539A2 (en) | improved prrs vaccines | |
| IN2012DN02736A (en) | ||
| UA106475C2 (en) | Method of pig vaccination against highly pathogenic reproductive and respiratory pig syndrome (hp prrs) | |
| PH12013502442A1 (en) | Inactivated dengue virus vaccine | |
| WO2007120673A3 (en) | Immunogenic wt-1 peptides and methods of use thereof | |
| MX2009008928A (en) | Compositions comprising polysaccharide conjugates and their use as vaccines. | |
| PH12012500950A1 (en) | Oral compositions containing extracts of myristica fragrans and related methods | |
| UA114286C2 (en) | Methods and compositions for vaccinating against staphylococcus aureus | |
| NZ591950A (en) | Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition | |
| NZ630868A (en) | Acellular pertussis vaccine | |
| CA2646574A1 (en) | Vaccine against mycoplasma and prrsv | |
| UA93901C2 (en) | Vaccine against mycoplasma prrs | |
| MX2010003719A (en) | Mycoplasma bovis vaccine. | |
| PH12013502179A1 (en) | Oral care compositions | |
| BR112016012393A2 (en) | VACCINE, AND, USE OF A COMBINATION OF A LIVE ATENUE PRRS VIRUS AND AN INACTIVATED LAWSONIA INTRACELLULARIS ANTIGEN | |
| WO2011074006A3 (en) | Vaccine composition | |
| EA201290319A1 (en) | APPLICATION OF L3 AND / OR L5 SOURCE AS A VACCINE OR DIAGNOSTIC MEANS FOR PARASITIC DISEASE | |
| BR112013007355A2 (en) | enhanced vaccine compositions |